Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25104109

Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Sep
First author
Fizazi K

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Oct;15(11):e475
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2014 Sep;15(10):1052-4. doi: 10.1016/S1470-2045(14)70332-8.
    note
    Source null
    related pmid
    25104108
    relationship
    Comment in
  3. citation
    Nat Rev Urol. 2014 Oct;11(10):545. doi: 10.1038/nrurol.2014.227.
    note
    Source null
    related pmid
    25155796
    relationship
    Comment in
  4. citation
    J Urol. 2015 Aug;194(2):392-3. doi: 10.1016/j.juro.2015.05.065.
    note
    Source null
    related pmid
    26195363
    relationship
    Comment in

Authors and identifiers

  1. name
    Fizazi K
    type
    Author
  2. name
    Scher HI
    type
    Author
  3. name
    Miller K
    type
    Author
  4. name
    Basch E
    type
    Author
  5. name
    Sternberg CN
    type
    Author
  6. name
    Cella D
    type
    Author
  7. name
    Forer D
    type
    Author
  8. name
    Hirmand M
    type
    Author
  9. name
    de Bono JS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Fizazi K
    type
    Author
  2. name
    Scher HI
    type
    Author
  3. name
    Miller K
    type
    Author
  4. name
    Basch E
    type
    Author
  5. name
    Sternberg CN
    type
    Author
  6. name
    Cella D
    type
    Author
  7. name
    Forer D
    type
    Author
  8. name
    Hirmand M
    type
    Author
  9. name
    de Bono JS
    type
    Author
bibliography ids
  1. nci-bib-c3ab57773111e61549b86329
book metadata
content sha256
61cf9934340366d5c40d19b3dc0791d2d421868160c3a8c3eeff24754d5a8f94
document type
citation
dois
  1. 10.1016/S1470-2045(14)70303-1
electronic publication date
display
2014 Aug 4
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25104109
immutable id
pubmed:25104109@61cf9934340366d5c40d19b3dc0791d2d421868160c3a8c3eeff24754d5a8f94
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
10
name
The Lancet. Oncology
nlm unique id
100957246
pages
1147-56
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Oct;15(11):e475
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2014 Sep;15(10):1052-4. doi: 10.1016/S1470-2045(14)70332-8.
    note
    Source null
    related pmid
    25104108
    relationship
    Comment in
  3. citation
    Nat Rev Urol. 2014 Oct;11(10):545. doi: 10.1038/nrurol.2014.227.
    note
    Source null
    related pmid
    25155796
    relationship
    Comment in
  4. citation
    J Urol. 2015 Aug;194(2):392-3. doi: 10.1016/j.juro.2015.05.065.
    note
    Source null
    related pmid
    26195363
    relationship
    Comment in
outcomes validated
false
pmid
25104109
provenance
batch id
69903be8ceab8801c81a
provider
NCBI PubMed ESummary
record sha256
7193408565a54ce183624b9cdcb039c9ca380a6f436d9a698d05256353b8fec8
response sha256
1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
retrieved at
2026-09-09T23:47:05.208886+00:00
publication date
display
2014 Sep
precision
month
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25104109/
title
Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial.

Preserved source evidence · Not medical advice